Call Anytime

669 2568 2596

Lorem ipsum dolor sit amet, consectet eiusmod tempor incididunt ut labore e rem ipsum dolor sit amet. sum dolor sit amet, consectet eiusmod.

Visiting Hours

Gallery Posts

Transjugular portosystemic stent shunt creation

Transjugular portosystemic stent shunt creation

Transjugular intrahepatic portosystemic shunt (TIPS) creation is a minimally invasive procedure used to alleviate portal hypertension in patients with liver disease. 

 

Indications for TIPS Creation

  1. Portal Hypertension: Patients with symptomatic portal hypertension refractory to medical management, often due to liver cirrhosis, portal vein thrombosis, or other liver diseases.
  2. Complications of Portal Hypertension: Refractory ascites, recurrent variceal bleeding, hepatorenal syndrome, or hepatic hydrothorax despite optimal medical therapy.
  3. Pre-transplant Bridging: In select cases, TIPS can serve as a bridge therapy to liver transplantation for patients with decompensated cirrhosis and severe portal hypertension.

 

Pre-procedure Preparation

  1. Patient Assessment:
    • Comprehensive evaluation of the patient’s medical history, liver function tests, imaging studies (such as ultrasound, CT scan, or MRI), and coagulation profile.
    • Assessment of the severity of portal hypertension, presence of varices, and risk of complications.
  2. Informed Consent:
    • Explanation of the TIPS procedure, its purpose, potential risks (such as bleeding, infection, hepatic encephalopathy, shunt dysfunction), benefits, and alternatives. Informed consent is obtained.

 

Procedure Steps

  1. Access and Catheterization:
    • The procedure is typically performed under local anesthesia and conscious sedation or general anesthesia, depending on the patient’s condition and tolerance.
    • Access is gained through the right internal jugular vein, and a catheter is advanced into the hepatic vein under fluoroscopic guidance.
  2. Portal Venous Pressure Measurement:
    • Before TIPS creation, portal venous pressure is measured to assess the severity of portal hypertension and guide shunt placement.
    • A pressure gradient of ≥ 10 mmHg between the portal vein and hepatic vein indicates significant portal hypertension and is often a threshold for TIPS creation.
  3. Shunt Creation:
    • A specialized catheter with a puncture needle is advanced through the liver parenchyma into the portal vein under fluoroscopic guidance.
    • A tract is created between the hepatic vein and portal vein using radiofrequency or balloon dilation techniques.
    • A stent (usually covered) is then deployed to maintain patency of the shunt and facilitate blood flow diversion from the portal vein to the systemic circulation.
  4. Post-shunt Angiography and Evaluation:
    • Contrast angiography is performed post-TIPS creation to confirm proper shunt placement, assess shunt patency, and evaluate for any complications such as stenosis or thrombosis.
    • Any residual stenosis or flow-limiting issues within the shunt or adjacent vessels may be addressed with balloon angioplasty or additional stent placement if necessary.

 

Benefits and Clinical Outcomes

  • Reduction in Portal Pressure: TIPS creation effectively reduces portal venous pressure, alleviating complications of portal hypertension such as ascites, variceal bleeding, and hepatorenal syndrome.
  • Symptom Relief: Improves symptoms associated with portal hypertension, including refractory ascites, recurrent variceal bleeding, and hepatic hydrothorax.
  • Bridge to Transplantation: In some cases, TIPS serves as a temporary measure to stabilize patients with severe portal hypertension while awaiting liver transplantation.
  • Improved Quality of Life: Patients often experience improved quality of life and functional status post-TIPS creation, with decreased hospitalizations and complications related to portal hypertension.

 

Risks and Considerations

  • Bleeding: Risk of bleeding at the access site, liver parenchyma, or within the shunt during the procedure.
  • Hepatic Encephalopathy: TIPS creation may increase the risk of hepatic encephalopathy due to altered portal blood flow and ammonia metabolism.
  • Shunt Dysfunction: Potential for shunt stenosis, occlusion, or dysfunction over time, necessitating regular monitoring and potential interventions.
  • Post-TIPS Syndrome: A transient syndrome characterized by abdominal pain, fever, and leukocytosis may occur post-TIPS creation but typically resolves with conservative management.

 

Follow-up and Long-term Management

  1. Clinical Follow-up:
    • Regular clinical assessments to monitor symptoms, liver function tests, and complications post-TIPS creation.
  2. Imaging Studies:
    • Periodic imaging studies (such as Doppler ultrasound, CT scan, or MRI) to assess shunt patency, flow rates, and any signs of shunt dysfunction or complications.
  3. Medication:
    • Adjustment of medications (such as diuretics, beta-blockers, or ammonia-lowering agents) based on clinical response and liver function parameters.
  4. Shunt Surveillance:
    • Surveillance protocols for TIPS patients to detect early signs of shunt stenosis or dysfunction and guide timely interventions.
  5. Lifestyle Modifications:
    • Recommendations for dietary changes, fluid restriction, and management of hepatic encephalopathy or ascites as needed post-TIPS creation.

 

Conclusion

TIPS creation is an effective intervention for managing complications of portal hypertension in patients with liver disease. Close collaboration between interventional radiologists, hepatologists, and transplant specialists is essential for the successful planning, execution, and long-term management of TIPS procedures. Regular follow-up, surveillance, and adherence to treatment strategies are crucial for optimizing outcomes and minimizing complications in TIPS patients.